Pole-Star Medichem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 106.52%
(FY 2022)
- Profit 168.03%
(FY 2022)
- Ebitda -110.06%
(FY 2022)
- Net Worth 17.03%
(FY 2022)
- Total Assets -14.84%
(FY 2022)
About Pole-Star Medichem
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sivasubramanian Shanmuganayagam and Chandrappa Rajendran serve as directors at the Company.
- CIN/LLPIN
U24232TN2006PTC058705
- Company No.
058705
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pole-Star Medichem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivasubramanian Shanmuganayagam  | Director | 31-Jan-2006 | Current |
| Chandrappa Rajendran | Director | 31-Jan-2006 | Current |
Financial Performance and Corporate Structure Insights of Pole-Star Medichem.
Pole-Star Medichem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 106.52% increase. The company also saw a substantial improvement in profitability, with a 168.03% increase in profit. The company's net worth Soared by an impressive increase of 17.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pole-Star Medichem?
In 2022, Pole-Star Medichem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pole-Star Ventures Private Limited
Active 22 years 1 monthSivasubramanian Shanmuganayagam is a mutual person
Pole-Star Distribution Private Limited
Active 17 years 6 monthsSivasubramanian Shanmuganayagam and Chandrappa Rajendran are mutual person
Pole-Star Digicom Private Limited
Active 13 years 4 monthsSivasubramanian Shanmuganayagam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pole-Star Medichem?
Unlock and access historical data on people associated with Pole-Star Medichem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pole-Star Medichem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pole-Star Medichem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
